Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Marco Pierotti

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Mice

Disorders

Physiology

Concepts & Ideas

Molecular Sequence Data

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Reid James F; Gariboldi Manuela; Sokolova Viktorija; Capobianco Patrizia; Lampis Andrea; Perrone Federica; Signoroni Stefano; Costa Aurora; Leo Ermanno; Pilotti Silvana; Pierotti Marco A
Integrative approach for prioritizing cancer genes in sporadic colon cancer.
Greco A; Borrello M G; Miranda C; Degl'innocenti D; Pierotti M A
Molecular pathology of differentiated thyroid cancer.
Conca Elena; Negri Tiziana; Gronchi Alessandro; Fumagalli Elena; Tamborini Elena; Pavan Giovanni Maria; Fermeglia Maurizio; Pierotti Marco A; Pricl Sabrina; Pilotti Silvana
Activate and resist: L576P-KIT in GIST.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Marco Pierotti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Reid James F; Gariboldi Manuela; Sokolova Viktorija; Capobianco Patrizia; Lampis Andrea; Perrone Federica; Signoroni Stefano; Costa Aurora; Leo Ermanno; Pilotti Silvana; Pierotti Marco A
Integrative approach for prioritizing cancer genes in sporadic colon cancer.
Genes, chromosomes & cancer 2009;48(11):953-62.
2009: Greco A; Borrello M G; Miranda C; Degl'innocenti D; Pierotti M A
Molecular pathology of differentiated thyroid cancer.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2009;53(5):440-53.
2009: Conca Elena; Negri Tiziana; Gronchi Alessandro; Fumagalli Elena; Tamborini Elena; Pavan Giovanni Maria; Fermeglia Maurizio; Pierotti Marco A; Pricl Sabrina; Pilotti Silvana
Activate and resist: L576P-KIT in GIST.
Molecular cancer therapeutics 2009;8(9):2491-5.
2009: Colombo M; Ripamonti C B; Pensotti V; Foglia C; Peissel B; Pierotti M A; Manoukian S; Radice P
An unusual BRCA2 allele carrying two splice site mutations.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):1143-4.
2009: Pastore Elisa; Perrone Federica; Orsenigo Marta; Mariani Luigi; Millefanti Clara; Riccio Stefano; Colombo Sarah; Cantù Giulio; Pierotti Marco A; Pilotti Silvana
Polymorphisms of Metabolizing Enzymes and Susceptibility to Ethmoid Intestinal-type Adenocarcinoma in Professionally Exposed Patients.
Translational oncology 2009;2(2):84-8.
2009: Gorla L; Mondellini P; Cuccuru G; Miccichè F; Cassinelli G; Cremona M; Pierotti M A; Lanzi C; Bongarzone I
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
Molecular carcinogenesis 2009;48(3):220-31.
2009: Stacchiotti Silvia; Tamborini Elena; Marrari Andrea; Brich Silvia; Rota Sara Arisi; Orsenigo Marta; Crippa Flavio; Morosi Carlo; Gronchi Alessandro; Pierotti Marco A; Casali Paolo G; Pilotti Silvana
Response to sunitinib malate in advanced alveolar soft part sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1096-104.
2009: Negri Tiziana; Pavan Giovanni Maria; Virdis Emanuela; Greco Angela; Fermeglia Maurizio; Sandri Marco; Pricl Sabrina; Pierotti Marco A; Pilotti Silvana; Tamborini Elena
T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense.
Journal of the National Cancer Institute 2009;101(3):194-204.
2009: Perrone F; Lampis A; Orsenigo M; Di Bartolomeo M; Gevorgyan A; Losa M; Frattini M; Riva C; Andreola S; Bajetta E; Bertario L; Leo E; Pierotti M A; Pilotti S
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(1):84-90.
2008: Miselli Francesca; Negri Tiziana; Gronchi Alessandro; Losa Marco; Conca Elena; Brich Silvia; Fumagalli Elena; Fiore Marco; Casali Paolo G; Pierotti Marco A; Tamborini Elena; Pilotti Silvana
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?
Translational oncology 2008;1(4):177-86.
2008: Colombo Mara; Giarola Monica; Mariani Luigi; Ripamonti Carla B; De Benedetti Virna; Sardella Michele; Losa Marco; Manoukian Siranoush; Peissel Bernard; Pierotti Marco A; Pilotti Silvana; Radice Paolo
Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(10):1262-70.
2008: Negri Tiziana; Tamborini Elena; Dagrada Gian Paolo; Greco Angela; Staurengo Samantha; Guzzo Marco; Locati Laura D; Carbone Antonino; Pierotti Marco A; Licitra Lisa; Pilotti Silvana
TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma.
Translational oncology 2008;1(3):121-8.
2008: Coradini Danila; Gariboldi Manuela; Fedeli Maya; Pierotti Marco A; Daidone Maria Grazia
Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.
Breast cancer research and treatment 2008;111(2):389-90.
2008: Mantovani Alberto; Pierotti Marco A
Cancer and inflammation: a complex relationship.
Cancer letters 2008;267(2):180-1.
2008: Borrello Maria Grazia; Degl'Innocenti Debora; Pierotti Marco A
Inflammation and cancer: the oncogene-driven connection.
Cancer letters 2008;267(2):262-70.
2008: Bozzi Fabio; Ferrari Andrea; Negri Tiziana; Conca Elena; Luca Da Riva; Losa Marco; Casieri Paola; Orsenigo Marta; Lampis Andrea; Meazza Cristina; Casanova Michela; Pierotti Marco A; Tamborini Elena; Pilotti Silvana
Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation.
Translational oncology 2008;1(2):95-101.
2008: Cappelletti Vera; Gariboldi Manuela; De Cecco Loris; Toffanin Sara; Reid James F; Lusa Lara; Bajetta Emilio; Celio Luigi; Greco Marco; Fabbri Alessandra; Pierotti Marco A; Daidone Maria Grazia
Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
Endocrine-related cancer 2008;15(2):439-49.
2008: Lusa Lara; Peissel Bernard; Manoukian Siranoush; Marchesi Edoardo; Radice Paolo; Pierotti Marco A; Gariboldi Manuela
Re: Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
Journal of the National Cancer Institute 2008;100(10):752-3; author reply 753-4.
2008: Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti M A
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
Cancer letters 2008;263(2):170-81.
2008: Miselli Francesca; Millefanti Clara; Conca Elena; Negri Tiziana; Piacenza Cristina; Pierotti Marco A; Tamborini Elena; Pilotti Silvana
PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors.
The American journal of surgical pathology 2008;32(5):738-43.
2008: Ferrario Cristina; Lavagni Paola; Gariboldi Manuela; Miranda Claudia; Losa Marco; Cleris Loredana; Formelli Franca; Pilotti Silvana; Pierotti Marco A; Greco Angela
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2008;88(5):474-81.
2008: Pierotti Marco A; Lombardo Claudio; Rosano Camillo
Nanotechnology: going small for a giant leap in cancer diagnostics and therapeutics.
Tumori 2008;94(2):191-6.
2008: Ringborg Ulrik; de Valeriola Dominique; van Harten Wim; Bosch Antonio Llombart; Lombardo Claudio; Nilsson Kenneth; Philip Thierry; Pierotti Marco A; Riegman Peter; Saghatchian Mahasti; Storme Guy; Tursz Thomas; Verellen Dirk
Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.
Tumori 2008;94(2):143-6.
2008: Mezzanzanica Delia; Fabbi Marina; Bagnoli Marina; Staurengo Samantha; Losa Marco; Balladore Emanuela; Alberti Paola; Lusa Lara; Ditto Antonino; Ferrini Silvano; Pierotti Marco A; Barbareschi Mattia; Pilotti Silvana; Canevari Silvana
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1726-33.
2008: Benvenuti Silvia; Frattini Milo; Arena Sabrina; Zanon Carlo; Cappelletti Vera; Coradini Danila; Daidone Maria Grazia; Pilotti Silvana; Pierotti Marco A; Bardelli Alberto
PIK3CA cancer mutations display gender and tissue specificity patterns.
Human mutation 2008;29(2):284-8.
2008: Loi Sherene; Haibe-Kains Benjamin; Desmedt Christine; Wirapati Pratyaksha; Lallemand Françoise; Tutt Andrew M; Gillet Cheryl; Ellis Paul; Ryder Kenneth; Reid James F; Daidone Maria G; Pierotti Marco A; Berns Els Mjj; Jansen Maurice Phm; Foekens John A; Delorenzi Mauro; Bontempi Gianluca; Piccart Martine J; Sotiriou Christos
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
BMC genomics 2008;9():239.
2007: Lusa Lara; McShane Lisa M; Reid James F; De Cecco Loris; Ambrogi Federico; Biganzoli Elia; Gariboldi Manuela; Pierotti Marco A
Challenges in projecting clustering results across gene expression-profiling datasets.
Journal of the National Cancer Institute 2007;99(22):1715-23.
2007: Donatello S; Fiorino A; Degl'Innocenti D; Alberti L; Miranda C; Gorla L; Bongarzone I; Rizzetti M G; Pierotti M A; Borrello M G
SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
Oncogene 2007;26(45):6546-59.
2007: Signoroni Stefano; Frattini Milo; Negri Tiziana; Pastore Elisa; Tamborini Elena; Casieri Paola; Orsenigo Marta; Da Riva Luca; Radice Paolo; Sala Paola; Gronchi Alessandro; Bertario Lucio; Pierotti Marco A; Pilotti Silvana
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5034-40.
2007: Raho G; Miranda C; Tamborini E; Pierotti M A; Greco A
Detection of novel mRNA splice variants of human ING4 tumor suppressor gene.
Oncogene 2007;26(36):5247-57.
2007: Perrone Federica; Mariani Luigi; Pastore Elisa; Orsenigo Marta; Suardi Simona; Marcomini Barbara; DaRiva Luca; Licitra Lisa; Carbone Antonino; Pierotti Marco A; Pilotti Silvana
p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
Cancer 2007;109(12):2461-5.
2007: Tamborini E; Casieri P; Miselli F; Orsenigo M; Negri T; Piacenza C; Stacchiotti S; Gronchi A; Pastorino U; Pierotti M A; Pilotti S
Analysis of potential receptor tyrosine kinase targets in intimal and mural sarcomas.
The Journal of pathology 2007;212(2):227-35.
2007: Daniotti Maria; Vallacchi Viviana; Rivoltini Licia; Patuzzo Roberto; Santinami Mario; Arienti Flavio; Cutolo Gianluca; Pierotti Marco A; Parmiani Giorgio; Rodolfo Monica
Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
International journal of cancer. Journal international du cancer 2007;120(11):2439-44.
2007: Appierto V; Villani M G; Cavadini E; Gariboldi M; De Cecco L; Pierotti M A; Lambert J R; Reid J; Tiberio P; Colombo N; Formelli F
Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
Oncogene 2007;26(27):3952-62.
2007: Miselli Francesca C; Casieri Paola; Negri Tiziana; Orsenigo Marta; Lagonigro M Stefania; Gronchi Alessandro; Fiore Marco; Casali Paolo G; Bertulli Rossella; Carbone Antonino; Pierotti Marco A; Tamborini Elena; Pilotti Silvana
c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2369-77.
2007: Bozzi Fabio; Tamborini Elena; Negri Tiziana; Pastore Elisa; Ferrari Andrea; Luksch Roberto; Casanova Michela; Pierotti Marco A; Bellani Franca Fossati; Pilotti Silvana
Evidence for activation of KIT, PDGFRalpha, and PDGFRbeta receptors in the Ewing sarcoma family of tumors.
Cancer 2007;109(8):1638-45.
2007: Manoukian Siranoush; Peissel Bernard; Pensotti Valeria; Barile Monica; Cortesi Laura; Stacchiotti Silvia; Terenziani Monica; Barbera Floriana; Pasquini Graziella; Frigerio Simona; Pierotti Marco A; Radice Paolo; Della-Torre Gabriella
Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
European journal of cancer (Oxford, England : 1990) 2007;43(3):601-6.
2007: Negri T; Casieri P; Miselli F; Orsenigo M; Piacenza C; Stacchiotti S; Bidoli P; Casali P G; Pierotti M A; Tamborini E; Pilotti S
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient.
British journal of cancer 2007;96(1):180-1.
2006: Licitra Lisa; Perrone Federica; Bossi Paolo; Suardi Simona; Mariani Luigi; Artusi Raffaella; Oggionni Maria; Rossini Chiara; Cantù Giulio; Squadrelli Massimo; Quattrone Pasquale; Locati Laura D; Bergamini Cristiana; Olmi Patrizia; Pierotti Marco A; Pilotti Silvana
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5630-6.
2006: Tamborini Elena; Miselli Francesca; Negri Tiziana; Lagonigro M Stefania; Staurengo Samantha; Dagrada Gian Paolo; Stacchiotti Silvia; Pastore Elisa; Gronchi Alessandro; Perrone Federica; Carbone Antonino; Pierotti Marco A; Casali Paolo G; Pilotti Silvana
Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):6920-8.
2006: Gorla L; Cantù M; Miccichè F; Patelli C; Mondellini P; Pierotti M A; Bongarzone I
RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism.
Cellular signalling 2006;18(12):2272-82.
2006: Perrone Federica; Suardi Simona; Pastore Elisa; Casieri Paola; Orsenigo Marta; Caramuta Stefano; Dagrada Gianpaolo; Losa Marco; Licitra Lisa; Bossi Paolo; Staurengo Samantha; Oggionni Maria; Locati Laura; Cantu Giulio; Squadrelli Massimo; Carbone Antonino; Pierotti Marco A; Pilotti Silvana
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6643-51.
2006: Cranston Aaron N; Carniti Cristiana; Oakhill Kim; Radzio-Andzelm Elzbieta; Stone Eric A; McCallion Andrew S; Hodgson Shirley; Clarke Sue; Mondellini Piera; Leyland Jean; Pierotti Marco A; Whittaker Joanne; Taylor Susan S; Bongarzone Italia; Ponder Bruce A J
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.
Cancer research 2006;66(20):10179-87.
2006: Frattini Milo; Perrone Federica; Suardi Simona; Balestra Debora; Caramuta Stefano; Colombo Federica; Licitra Lisa; Cantù Giulio; Pierotti Marco A; Pilotti Silvana
Phenotype-genotype correlation: challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.
Head & neck 2006;28(10):909-15.
2006: Canevari Silvana; Gariboldi Manuela; Reid James F; Bongarzone Italia; Pierotti Marco A
Molecular predictors of response and outcome in ovarian cancer.
Critical reviews in oncology/hematology 2006;60(1):19-37.
2006: Tamborini E; Pricl S; Negri T; Lagonigro M S; Miselli F; Greco A; Gronchi A; Casali P G; Ferrone M; Fermeglia M; Carbone A; Pierotti M A; Pilotti S
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.
Oncogene 2006;25(45):6140-6.
2006: Caramuta Stefano; De Cecco Loris; Reid James F; Zannini Laura; Gariboldi Manuela; Kjeldsen Lars; Pierotti Marco A; Delia Domenico
Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR.
International journal of cancer. Journal international du cancer 2006;119(7):1599-606.
2006: Frattini Milo; Gallino Gianfrancesco; Signoroni Stefano; Balestra Debora; Battaglia Luigi; Sozzi Gabriella; Leo Ermanno; Pilotti Silvana; Pierotti Marco A
Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
Annals of the New York Academy of Sciences 2006;1075():185-90.
2006: Monte Martin; Simonatto Marta; Peche Leticia Y; Bublik Debora R; Gobessi Stefania; Pierotti Marco A; Rodolfo Monica; Schneider Claudio
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(30):11160-5.
2006: Miranda Claudia; Roccato Emanuela; Raho Giovanna; Pagliardini Sonia; Pierotti Marco A; Greco Angela
The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF-kappaB pathway.
Journal of cellular physiology 2006;208(1):154-60.
2006: Cranston Aaron; Carniti Cristiana; Martin Sam; Mondellini Piera; Hooks Yvette; Leyland Jean; Hodgson Shirley; Clarke Sue; Pierotti Marco; Ponder Bruce A J; Bongarzone Italia
A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation.
Molecular endocrinology (Baltimore, Md.) 2006;20(7):1633-43.
2006: Ferrone Marco; Perrone Federica; Tamborini Elena; Paneni Maria Silvia; Fermeglia Maurizio; Suardi Simona; Pastore Elisa; Delia Domenico; Pierotti Marco A; Pricl Sabrina; Pilotti Silvana
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y).
Molecular cancer therapeutics 2006;5(6):1467-73.
2006: Lusa L; Cappelletti V; Gariboldi M; Ferrario C; De Cecco L; Reid J F; Toffanin S; Gallus G; McShane L M; Daidone M G; Pierotti M A
Questioning the utility of pooling samples in microarray experiments with cell lines.
The International journal of biological markers 2006;21(2):67-73.
2006: Carniti Cristiana; Belluco Sara; Riccardi Elena; Cranston Aaron N; Mondellini Piera; Ponder Bruce A J; Scanziani Eugenio; Pierotti Marco A; Bongarzone Italia
The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease.
The American journal of pathology 2006;168(4):1262-75.
2006: Lagonigro M S; Tamborini E; Negri T; Staurengo S; Dagrada G P; Miselli F; Gabanti E; Greco A; Casali P G; Carbone A; Pierotti M A; Pilotti S
PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma.
The Journal of pathology 2006;208(5):615-23.
2005: Rodolfo Monica; Pierotti Marco A; Parmiani Giorgio
A merging duo in melanoma formation.
The Journal of investigative dermatology 2005;125(6):xii-xiii.
2005: Frattini Milo; Signoroni Stefano; Pilotti Silvana; Bertario Lucio; Benvenuti Silvia; Zanon Carlo; Bardelli Alberto; Pierotti Marco A
Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer.
Cancer research 2005;65(23):11227.
2005: Borrello Maria Grazia; Alberti Luisella; Fischer Andrew; Degl'innocenti Debora; Ferrario Cristina; Gariboldi Manuela; Marchesi Federica; Allavena Paola; Greco Angela; Collini Paola; Pilotti Silvana; Cassinelli Giuliana; Bressan Paola; Fugazzola Laura; Mantovani Alberto; Pierotti Marco A
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(41):14825-30.
2005: Frattini Milo; Carnevali Ileana; Signoroni Stefano; Balestra Debora; Moiraghi Maria Luisa; Radice Paolo; Varesco Liliana; Gismondi Viviana; Ballardini Giovanni; Sala Paola; Pierotti Marco A; Pilotti Silvana; Bertario Lucio
Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(8):2049-52.
2005: Ponti Dario; Costa Aurora; Zaffaroni Nadia; Pratesi Graziella; Petrangolini Giovanna; Coradini Danila; Pilotti Silvana; Pierotti Marco A; Daidone Maria Grazia
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.
Cancer research 2005;65(13):5506-11.
2005: Perrone Federica; Tamborini Elena; Dagrada Gian Paolo; Colombo Federica; Bonadiman Lorena; Albertini Veronica; Lagonigro Maria Stefania; Gabanti Elisa; Caramuta Stefano; Greco Angela; Torre Gabriella Della; Gronchi Alessandro; Pierotti Marco Alessandro; Pilotti Silvana
9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
Cancer 2005;104(1):159-69.
2005: Reid James F; Lusa Lara; De Cecco Loris; Coradini Danila; Veneroni Silvia; Daidone Maria Grazia; Gariboldi Manuela; Pierotti Marco A
Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
Journal of the National Cancer Institute 2005;97(12):927-30.
2005: Dalla E; Mignone F; Verardo R; Marchionni L; Marzinotto S; Lazarevic D; Reid J F; Marzio R; Klaric E; Licastro D; Marcuzzi G; Gambetta R; Pierotti M A; Pesole G; Schneider C
Discovery of 342 putative new genes from the analysis of 5'-end-sequenced full-length-enriched cDNA human transcripts.
Genomics 2005;85(6):739-51.
2005: Di Stasi Delia; Vallacchi Viviana; Campi Valentina; Ranzani Tiziana; Daniotti Maria; Chiodini Elena; Fiorentini Silvia; Greeve Isabell; Prinetti Alessandro; Rivoltini Licia; Pierotti Marco A; Rodolfo Monica
DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis.
International journal of cancer. Journal international du cancer 2005;115(2):224-30.
2005: Frattini Milo; Balestra Debora; Verderio Paolo; Gallino Gianfrancesco; Leo Ermanno; Sozzi Gabriella; Pierotti Marco A; Daidone Maria Grazia
Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3163-4; author reply 3164-5.
2005: Aiello Antonella; Cioni Katia; Gobbo Morena; Collini Paola; Gullo Maria; Della Torre Gabriella; Passerini Emanuele; Ferrando Barbara; Pilotti Silvana; Pierotti Marco A; Pasini Barbara
The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case.
Surgery 2005;137(5):574-6.
2005: Roccato Emanuela; Bressan Paola; Sabatella Guido; Rumio Cristiano; Vizzotto Laura; Pierotti Marco A; Greco Angela
Proximity of TPR and NTRK1 rearranging loci in human thyrocytes.
Cancer research 2005;65(7):2572-6.
2005: De Cecco L; Gariboldi M; Reid J F; Lagonigro M S; Tamborini E; Albertini V; Staurengo S; Pilotti S; Pierotti M A
Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript.
Histopathology 2005;46(3):334-41.
2005: Tamborini Elena; Gabanti Elisa; Lagonigro M Stefania; Negri Tiziana; Pilotti Silvana; Pierotti Marco A; Pricl Sabrina
KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.
Cancer research 2005;65(3):1115; author reply 1115.
2005: Roccato Emanuela; Miranda Claudia; Raho Giovanna; Pagliardini Sonia; Pierotti Marco A; Greco Angela
Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.
The Journal of biological chemistry 2005;280(5):3382-9.
2004: Tamborini Elena; Bonadiman Lorena; Negri Tiziana; Greco Angela; Staurengo Samantha; Bidoli Paolo; Pastorino Ugo; Pierotti Marco A; Pilotti Silvana
Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8214-9.
2004: Licitra L; Suardi S; Bossi P; Locati L D; Mariani L; Quattrone P; Lo Vullo S; Oggionni M; Olmi P; Cantù G; Pierotti M A; Pilotti S
Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4901-6.
2004: Casali Paolo G; Messina Antonella; Stacchiotti Silvia; Tamborini Elena; Crippa Flavio; Gronchi Alessandro; Orlandi Rosaria; Ripamonti Carla; Spreafico Carlo; Bertieri Raffaello; Bertulli Rossella; Colecchia Maurizio; Fumagalli Elena; Greco Angela; Grosso Federica; Olmi Patrizia; Pierotti Marco A; Pilotti Silvana
Imatinib mesylate in chordoma.
Cancer 2004;101(9):2086-97.
2004: Bertario Lucio; Russo Antonio; Sala Paola; Varesco Liliana; Crucianelli Rosella; Frattini Milo; Pierotti Marco A; Radice Paolo;
APC genotype is not a prognostic factor in familial adenomatous polyposis patients with colorectal cancer.
Diseases of the colon and rectum 2004;47(10):1662-9.
2004: De Cecco Loris; Marchionni Luigi; Gariboldi Manuela; Reid James F; Lagonigro M Stefania; Caramuta Stefano; Ferrario Cristina; Bussani Erica; Mezzanzanica Delia; Turatti Fabio; Delia Domenico; Daidone Maria G; Oggionni Maria; Bertuletti Norma; Ditto Antonino; Raspagliesi Francesco; Pilotti Silvana; Pierotti Marco A; Canevari Silvana; Schneider Claudio
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.
Oncogene 2004;23(49):8171-83.
2004: Degl'Innocenti Debora; Arighi Elena; Popsueva Anna; Sangregorio Romina; Alberti Luisella; Rizzetti Maria Grazia; Ferrario Cristina; Sariola Hannu; Pierotti Marco A; Borrello Maria Grazia
Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching.
Oncogene 2004;23(44):7297-309.
2004: Frattini Milo; Ferrario Cristina; Bressan Paola; Balestra Debora; De Cecco Loris; Mondellini Piera; Bongarzone Italia; Collini Paola; Gariboldi Manuela; Pilotti Silvana; Pierotti Marco A; Greco Angela
Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.
Oncogene 2004;23(44):7436-40.
2004: Daniotti Maria; Oggionni Maria; Ranzani Tiziana; Vallacchi Viviana; Campi Valentina; Di Stasi Delia; Torre Gabriella Della; Perrone Federica; Luoni Chiara; Suardi Simona; Frattini Milo; Pilotti Silvana; Anichini Andrea; Tragni Gabrina; Parmiani Giorgio; Pierotti Marco A; Rodolfo Monica
BRAF alterations are associated with complex mutational profiles in malignant melanoma.
Oncogene 2004;23(35):5968-77.
2004: Tamborini Elena; Bonadiman Lorena; Greco Angela; Albertini Veronica; Negri Tiziana; Gronchi Alessandro; Bertulli Rossella; Colecchia Maurizio; Casali Paolo G; Pierotti Marco A; Pilotti Silvana
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient.
Gastroenterology 2004;127(1):294-9.
2004: Frattini Milo; Balestra Debora; Suardi Simona; Oggionni Maria; Alberici Paola; Radice Paolo; Costa Aurora; Daidone Maria Grazia; Leo Ermanno; Pilotti Silvana; Bertario Lucio; Pierotti Marco A
Different genetic features associated with colon and rectal carcinogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4015-21.
2004: Arighi Elena; Popsueva Anna; Degl'Innocenti Debora; Borrello Maria Grazia; Carniti Cristiana; Perälä Nina M; Pierotti Marco A; Sariola Hannu
Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
Molecular endocrinology (Baltimore, Md.) 2004;18(4):1004-17.
2004: Dagrada G P; Negri T; Tamborini E; Pierotti M A; Pilotti S
Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry.
Histopathology 2004;44(3):301-2.
2004: Tamborini Elena; Bonadiman Lorena; Greco Angela; Gronchi Alessandro; Riva Carla; Bertulli Rossella; Casali Paolo G; Pierotti Marco A; Pilotti Silvana
Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):938-43.
2004: Daidone Maria Grazia; Costa Aurora; Frattini Milo; Balestra Debora; Bertario Lucio; Pierotti Marco A
Correspondence re: T. Zhang et al., Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res., 61: 8664-8667, 2001.
Cancer research 2004;64(2):776-7; author reply 777-9.
2004: Pierotti Marco A; Arighi Elena; Degl'innocenti Debora; Borrello Maria Grazia
RET activation in medullary carcinomas.
Cancer treatment and research 2004;122():389-415.
2004: Greco Angela; Roccato Emanuela; Pierotti Marco A
TRK oncogenes in papillary thyroid carcinoma.
Cancer treatment and research 2004;122():207-19.
2003: Sozzi Gabriella; Conte Davide; Leon MariaElena; Ciricione Rosalia; Roz Luca; Ratcliffe Cathy; Roz Elena; Cirenei Nicola; Bellomi Massimo; Pelosi Giuseppe; Pierotti Marco A; Pastorino Ugo
Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3902-8.
2003: Bongarzone Italia; Carniti Cristiana; Perego Carla; Mondellini Piera; Pierotti Marco Alessandro
RETMEN2A and RETMEN2B oncoproteins are targets of PP1 inhibitor.
Tumori 2003;89(5):550-2.
2003: Bongarzone Italia; Pierotti Marco A
The molecular basis of thyroid epithelial tumorigenesis.
Tumori 2003;89(5):514-6.
2003: Perrone Federica; Tabano Silvia; Colombo Federica; Dagrada Gianpaolo; Birindelli Sarah; Gronchi Alessandro; Colecchia Maurizio; Pierotti Marco A; Pilotti Silvana
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4132-8.
2003: Dagrada Gian Paolo; Mezzelani Alessandra; Alasio Loredana; Ruggeri Mario; Romanò Roberta; Pierotti Marco A; Pilotti Silvana
HER-2/neu assessment in primary chemotherapy treated breast carcinoma: no evidence of gene profile changing.
Breast cancer research and treatment 2003;80(2):207-14.
2003: Tamborini Elena; Bonadiman Lorena; Albertini Veronica; Pierotti Marco A; Pilotti Silvana
Re: Potential use of imatinib in Ewing's sarcoma: evidence for in vitro and in vivo activity.
Journal of the National Cancer Institute 2003;95(14):1087-8; author reply 1088-9.
2003: Perrone Federica; Oggionni Maria; Birindelli Sarah; Suardi Simona; Tabano Silvia; Romano Roberta; Moiraghi Maria Luisa; Bimbi Gabriella; Quattrone Pasquale; Cantu Giulio; Pierotti Marco A; Licitra Lisa; Pilotti Silvana
TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.
International journal of cancer. Journal international du cancer 2003;105(2):196-203.
2003: Carniti Cristiana; Perego Carla; Mondellini Piera; Pierotti Marco Alessandro; Bongarzone Italia
PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting.
Cancer research 2003;63(9):2234-43.
2003: Bertario L; Russo A; Sala P; Varesco L; Giarola M; Mondini P; Pierotti M; Spinelli P; Radice P;
Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1698-707.
2003: Alberti Luisella; Carniti Cristiana; Miranda Claudia; Roccato Emanuela; Pierotti Marco A
RET and NTRK1 proto-oncogenes in human diseases.
Journal of cellular physiology 2003;195(2):168-86.
2003: Ranzi Valeria; Meakin Susan O; Miranda Claudia; Mondellini Piera; Pierotti Marco A; Greco Angela
The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.
Endocrinology 2003;144(3):922-8.
2003: Roccato Emanuela; Pagliardini Sonia; Cleris Loredana; Canevari Silvana; Formelli Franca; Pierotti Marco A; Greco Angela
Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
Oncogene 2003;22(6):807-18.
2003: Frattini Milo; Balestra Debora; Pilotti Silvana; Bertario Lucio; Pierotti Marco A
Tumor location and detection of k-ras mutations in stool from colorectal cancer patients.
Journal of the National Cancer Institute 2003;95(1):72-3; author reply 73.
2002: Miranda Claudia; Zanotti Giuseppe; Pagliardini Sonia; Ponzetto Carola; Pierotti Marco A; Greco Angela
Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.
Oncogene 2002;21(54):8334-9.
2002: Roccato E; Miranda C; Ranzi V; Gishizki M; Pierotti M A; Greco A
Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc.
British journal of cancer 2002;87(6):645-53.
2002: Tamborini Elena; Bonadiman Lorena; Moiraghi Luisa; Pilotti Silvana; Pierotti Marco A
KIT activation in soft tissue sarcomas.
American journal of clinical pathology 2002;118(3):472-3; author reply 473.
2002: Daidone Maria Grazia; Veneroni Silvia; Cappelletti Vera; Radice Paolo; Pierotti Marco A; Younes Mamoun
Estrogen receptor-beta expression in hereditary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3752-3; author reply 3753.
2002: Borrello Maria Grazia; Mercalli Elena; Perego Carla; Degl'Innocenti Debora; Ghizzoni Simona; Arighi Elena; Eroini Barbara; Rizzetti Maria Grazia; Pierotti Marco A
Differential interaction of Enigma protein with the two RET isoforms.
Biochemical and biophysical research communications 2002;296(3):515-22.
2002: Tamborini Elena; Agus Viviana; Perrone Federica; Papini Daniela; Romanò Roberta; Pasini Barbara; Gronchi Alessandro; Colecchia Maurizio; Rosai Juan; Pierotti Marco A; Pilotti Silvana
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases.
Laboratory investigation; a journal of technical methods and pathology 2002;82(5):609-18.
2002: Miranda Claudia; Di Virgilio Michela; Selleri Silvia; Zanotti Giuseppe; Pagliardini Sonia; Pierotti Marco A; Greco Angela
Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutations.
The Journal of biological chemistry 2002;277(8):6455-62.
2001: Mezzelani A; Mariani L; Tamborini E; Agus V; Riva C; Lo Vullo S; Fabbri A; Stumbo M; Azzarelli A; Casali P G; Gronchi A; Sozzi G; Pierotti M A; Pilotti S
SYT-SSX fusion genes and prognosis in synovial sarcoma.
British journal of cancer 2001;85(10):1535-9.
2001: Casadei S; Cortesi L; Pensotti V; Radice P; Pierotti M; Amadori D; Calistri D
Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method.
British journal of cancer 2001;85(6):845-9.
2001: Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot T J; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti M A
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
British journal of cancer 2001;85(6):836-44.
2001: Agus V; Tamborini E; Mezzelani A; Pierotti M A; Pilotti S
Re: A novel fusion gene, SYT-SSX4, in synovial sarcoma.
Journal of the National Cancer Institute 2001;93(17):1347-9.
2001: Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti M A; Pilotti S
c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
British journal of cancer 2001;85(3):405-11.
2001: Mercalli E; Ghizzoni S; Arighi E; Alberti L; Sangregorio R; Radice M T; Gishizky M L; Pierotti M A; Borrello M G
Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
Oncogene 2001;20(27):3475-85.
2001: Birindelli S; Perrone F; Oggionni M; Lavarino C; Pasini B; Vergani B; Ranzani G N; Pierotti M A; Pilotti S
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.
Laboratory investigation; a journal of technical methods and pathology 2001;81(6):833-44.
2001: Sozzi G; Conte D; Mariani L; Lo Vullo S; Roz L; Lombardo C; Pierotti M A; Tavecchio L
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
Cancer research 2001;61(12):4675-8.
2001: Tamborini E; Della Torre G; Lavarino C; Azzarelli A; Carpinelli P; Pierotti M A; Pilotti S
Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
International journal of cancer. Journal international du cancer 2001;92(6):790-6.
2001: Pierotti M A
Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma.
Cancer letters 2001;166(1):1-7.
2001: Greco A; Roccato E; Miranda C; Cleris L; Formelli F; Pierotti M A
Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement.
International journal of cancer. Journal international du cancer 2001;92(3):354-60.
2001: Perotti D; Testi M A; Mondini P; Pilotti S; Green E D; Pession A; Sozzi G; Pierotti M A; Fossati-Bellani F; Radice P
Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours.
Genes, chromosomes & cancer 2001;31(1):42-7.
2001: Tamborini E; Agus V; Mezzelani A; Riva C; Sozzi G; Azzarelli A; Pierotti M A; Pilotti S
Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma.
British journal of cancer 2001;84(8):1087-94.
2001: Bertario L; Russo A; Sala P; Eboli M; Giarola M; D'amico F; Gismondi V; Varesco L; Pierotti M A; Radice P;
Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis.
International journal of cancer. Journal international du cancer 2001;95(2):102-7.
2001: Lindahl M; Poteryaev D; Yu L; Arumae U; Timmusk T; Bongarzone I; Aiello A; Pierotti M A; Airaksinen M S; Saarma M
Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells.
The Journal of biological chemistry 2001;276(12):9344-51.
2000: Mezzelani A; Dagrada G P; Sozzi G; Pierotti M A; Pilotti S
SYT-SSX fusion transcripts and epithelial differentiation in synovial sarcoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2000;9(4):234-5.
2000: Lavarino C; Pilotti S; Oggionni M; Gatti L; Perego P; Bresciani G; Pierotti M A; Scambia G; Ferrandina G; Fagotti A; Mangioni C; Lucchini V; Vecchione F; Bolis G; Scarfone G; Zunino F
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3936-45.
2000: Mezzelani A; Sozzi G; Nessling M; Riva C; Della Torre G; Testi M A; Azzarelli A; Pierotti M A; Lichter P; Pilotti S
Low grade fibromyxoid sarcoma. a further low-grade soft tissue malignancy characterized by a ring chromosome.
Cancer genetics and cytogenetics 2000;122(2):144-8.
2000: Pilotti S; Mezzelani A; Vergani B; Minoletti F; Cristofori E; Sozzi G; Pierotti M A
Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2000;8(3):216-21.
2000: Mastrangelo T; Modena P; Tornielli S; Bullrich F; Testi M A; Mezzelani A; Radice P; Azzarelli A; Pilotti S; Croce C M; Pierotti M A; Sozzi G
A novel zinc finger gene is fused to EWS in small round cell tumor.
Oncogene 2000;19(33):3799-804.
2000: Mancuso T; Mezzelani A; Riva C; Fabbri A; Dal Bo L; Sampietro G; Perego P; Casali P; Zunino F; Sozzi G; Pierotti M A; Pilotti S
Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma.
Laboratory investigation; a journal of technical methods and pathology 2000;80(6):805-13.
2000: Delia D; Mizutani S; Panigone S; Tagliabue E; Fontanella E; Asada M; Yamada T; Taya Y; Prudente S; Saviozzi S; Frati L; Pierotti M A; Chessa L
ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes.
British journal of cancer 2000;82(12):1938-45.
2000: Bunone G; Uggeri M; Mondellini P; Pierotti M A; Bongarzone I
RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Cancer research 2000;60(11):2845-9.
2000: Pilotti S; Della Torre G; Mezzelani A; Tamborini E; Azzarelli A; Sozzi G; Pierotti M A
The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma.
British journal of cancer 2000;82(7):1271-5.
2000: Birindelli S; Tragni G; Bartoli C; Ranzani G N; Rilke F; Pierotti M A; Pilotti S
Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma.
International journal of cancer. Journal international du cancer 2000;86(2):255-61.
2000: Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti M A; Severini A
TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2000;9(1):41-6.
2000: Lanzi C; Cassinelli G; Pensa T; Cassinis M; Gambetta R A; Borrello M G; Menta E; Pierotti M A; Zunino F
Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.
International journal of cancer. Journal international du cancer 2000;85(3):384-90.
2000: Calistri D; Presciuttini S; Buonsanti G; Radice P; Gazzoli I; Pensotti V; Sala P; Eboli M; Andreola S; Russo A; Pierotti M; Bertario L; Ranzani G N
Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition.
International journal of cancer. Journal international du cancer 2000;89(1):87-91.
2000: Greco A; Villa R; Fusetti L; Orlandi R; Pierotti M A
The Gly571Arg mutation, associated with the autonomic and sensory disorder congenital insensitivity to pain with anhidrosis, causes the inactivation of the NTRK1/nerve growth factor receptor.
Journal of cellular physiology 2000;182(1):127-33.
1999: Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti M A; Bongarzone I
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
The American journal of pathology 1999;155(6):1967-76.
1999: Mezzelani A; Tornielli S; Minoletti F; Pierotti M A; Sozzi G; Pilotti S
Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group.
British journal of cancer 1999;81(4):586-91.
1999: Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti M A; Pastorino U
Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2689-92.
1999: Butò S; Pierotti M A; Tamborini E; Della Torre G; Lavarino C; Rilke F; Pilotti S
Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1999;8(3):125-30.
1999: Bongarzone I; Vigano E; Alberti L; Mondellini P; Uggeri M; Pasini B; Borrello M G; Pierotti M A
The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein.
Oncogene 1999;18(34):4833-8.
1999: Sard L; Accornero P; Tornielli S; Delia D; Bunone G; Campiglio M; Colombo M P; Gramegna M; Croce C M; Pierotti M A; Sozzi G
The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(15):8489-92.
1999: Mezzelani A; Alasio L; Bartoli C; Bonora M G; Pierotti M A; Rilke F; Pilotti S
c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.
British journal of cancer 1999;80(3-4):519-25.
1999: Giarola M; Stagi L; Presciuttini S; Mondini P; Radice M T; Sala P; Pierotti M A; Bertario L; Radice P
Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation.
Human mutation 1999;13(2):116-23.
1998: Minoletti F; Sozzi G; Tornielli S; Pilotti S; Azzarelli A; Pierotti M A; Radice P
A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation.
The Journal of pathology 1998;186(4):434-7.
1998: Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti M A; Croce C M; Pilotti S
Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Cancer research 1998;58(22):5032-7.
1998: Pilotti S; Lavarino C; Mezzelani A; Della Torre C; Minoletti F; Sozzi G; Azzarelli A; Rilke F; Pierotti M A
Limited role of TP53 and TP53-related genes in myxoid liposarcoma.
Tumori 1998;84(5):571-7.
1998: Greco A; Fusetti L; Villa R; Sozzi G; Minoletti F; Mauri P; Pierotti M A
Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans.
Oncogene 1998;17(10):1313-9.
1998: Alberti L; Borrello M G; Ghizzoni S; Torriti F; Rizzetti M G; Pierotti M A
Grb2 binding to the different isoforms of Ret tyrosine kinase.
Oncogene 1998;17(9):1079-87.
1998: Giarola M; Wells D; Mondini P; Pilotti S; Sala P; Azzarelli A; Bertario L; Pierotti M A; Delhanty J D; Radice P
Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours.
British journal of cancer 1998;78(5):582-7.
1998: Mezzelani A; Sozzi G; Pierotti M A; Pilotti S
Morpho-immunophenotypic-genotypic infidelity in synovial sarcoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(4):232-3.
1998: Marchetti A; Pellegrini S; Sozzi G; Bertacca G; Gaeta P; Buttitta F; Carnicelli V; Griseri P; Chella A; Angeletti C A; Pierotti M; Bevilacqua G
Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
British journal of cancer 1998;78(1):73-8.
1998: Buonsanti G; Presciuttini S; Radice P; Pierotti M A; Bertario L; Ranzani G N
Rapid assessment of replication error phenotype in gastric cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(3):168-73.
1998: Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti M A
Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
The Journal of pathology 1998;185(2):188-90.
1998: Perotti D; Mondini P; Giardini R; Ferrari A; Massimino M; Gambirasio F; Pierotti M A; Fossati-Bellani F; Radice P
No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(6):627-31.
1998: De Gregorio L; Manenti G; Incarbone M; Pilotti S; Pastorino U; Pierotti M A; Dragani T A
Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma.
International journal of cancer. Journal international du cancer 1998;79(3):269-72.
1998: Bongarzone I; Vigano E; Alberti L; Borrello M G; Pasini B; Greco A; Mondellini P; Smith D P; Ponder B A; Romeo G; Pierotti M A
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Oncogene 1998;16(18):2295-301.
1998: Pilotti S; Mezzelani A; Azzarelli A; Rilke F; Pierotti M A
bcl-2 expression in synovial sarcoma.
The Journal of pathology 1998;184(3):337-9.
1998: Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti M A
Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
Oncogene 1998;16(6):809-16.
1998: Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti M A
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):223-8.
1998: Gariboldi M; Vivat V; De Gregorio L; Manenti G; Chiariello E; Falvella F S; Pierotti M A; Dragani T A
Analysis of the retinoic acid receptor alpha gene as a candidate for the pulmonary adenoma resistance 1 gene.
Molecular carcinogenesis 1998;21(1):13-6.
1998: De Benedetti V M; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti M A
Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
Human mutation 1998;12(3):215.
1998: Manenti G; De Gregorio L; Gariboldi M; Falvella F S; Zanesi N; Pierotti M A; Dragani T A
Genetic mapping of cancer susceptibility/resistance loci in the mouse.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;154():292-7.
1998: Pierotti M A; Vigneri P; Bongarzone I
Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;154():237-47.
1998: Lavarino C; Corletto V; Mezzelani A; Della Torre G; Bartoli C; Riva C; Pierotti M A; Rilke F; Pilotti S
Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma.
British journal of cancer 1998;77(1):125-30.
1997: Pilotti S; Collini P; Mariani L; Placucci M; Bongarzone I; Vigneri P; Cipriani S; Falcetta F; Miceli R; Pierotti M A; Rilke F
Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.
The American journal of surgical pathology 1997;21(12):1466-73.
1997: Sozzi G; Tornielli S; Tagliabue E; Sard L; Pezzella F; Pastorino U; Minoletti F; Pilotti S; Ratcliffe C; Veronese M L; Goldstraw P; Huebner K; Croce C M; Pierotti M A
Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
Cancer research 1997;57(23):5207-12.
1997: Siprashvili Z; Sozzi G; Barnes L D; McCue P; Robinson A K; Eryomin V; Sard L; Tagliabue E; Greco A; Fusetti L; Schwartz G; Pierotti M A; Croce C M; Huebner K
Replacement of Fhit in cancer cells suppresses tumorigenicity.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(25):13771-6.
1997: Bocciardi R; Mograbi B; Pasini B; Borrello M G; Pierotti M A; Bourget I; Fischer S; Romeo G; Rossi B
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck.
Oncogene 1997;15(19):2257-65.
1997: Pezzella F; Pastorino U; Tagliabue E; Andreola S; Sozzi G; Gasparini G; Menard S; Gatter K C; Harris A L; Fox S; Buyse M; Pilotti S; Pierotti M; Rilke F
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.
The American journal of pathology 1997;151(5):1417-23.
1997: Manenti G; De Gregorio L; Pilotti S; Falvella F S; Incarbone M; Ravagnani F; Pierotti M A; Dragani T A
Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis.
Carcinogenesis 1997;18(10):1917-20.
1997: Manenti G; Gariboldi M; Fiorino A; Zanesi N; Pierotti M A; Dragani T A
Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression.
Cancer research 1997;57(19):4164-6.
1997: Sard L; Tornielli S; Gallinari P; Minoletti F; Jiricny J; Lettieri T; Pierotti M A; Sozzi G; Radice P
Chromosomal localizations and molecular analysis of TDG gene-related sequences.
Genomics 1997;44(2):222-6.
1997: Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2858-65.
1997: Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani G N; Bertario L; Pierotti M A
Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes.
Genes, chromosomes & cancer 1997;19(3):135-42.
1997: Aiello A; Delia D; Giardini R; Alasio L; Bartoli C; Pierotti M A; Pilotti S
PCR analysis of IgH and BCL2 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(3):154-60.
1997: Bongarzone I; Butti M G; Fugazzola L; Pacini F; Pinchera A; Vorontsova T V; Demidchik E P; Pierotti M A
Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas.
Genomics 1997;42(2):252-9.
1997: Sozzi G; Sard L; De Gregorio L; Marchetti A; Musso K; Buttitta F; Tornielli S; Pellegrini S; Veronese M L; Manenti G; Incarbone M; Chella A; Angeletti C A; Pastorino U; Huebner K; Bevilaqua G; Pilotti S; Croce C M; Pierotti M A
Association between cigarette smoking and FHIT gene alterations in lung cancer.
Cancer research 1997;57(11):2121-3.
1997: Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti M A
Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Genes, chromosomes & cancer 1997;19(2):112-23.
1997: Ceccherini I; Pasini B; Pacini F; Gullo M; Bongarzone I; Romei C; Santamaria G; Matera I; Mondellini P; Scopsi L; Pinchera A; Pierotti M A; Romeo G
Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene.
Oncogene 1997;14(21):2609-12.
1997: Debernardi S; Fontanella E; De Gregorio L; Pierotti M A; Delia D
Identification of a novel human kinesin-related gene (HK2) by the cDNA differential display technique.
Genomics 1997;42(1):67-73.
1997: Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed J C; Pierotti M A
Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Oncogene 1997;14(18):2137-47.
1997: Arighi E; Alberti L; Torriti F; Ghizzoni S; Rizzetti M G; Pelicci G; Pasini B; Bongarzone I; Piutti C; Pierotti M A; Borrello M G
Identification of Shc docking site on Ret tyrosine kinase.
Oncogene 1997;14(7):773-82.
1997: Sozzi G; Minoletti F; Miozzo M; Sard L; Musso K; Azzarelli A; Pierotti M A; Pilotti S
Relevance of cytogenetic and fluorescent in situ hybridization analyses in the clinical assessment of soft tissue sarcoma.
Human pathology 1997;28(2):134-42.
1997: Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti M A
Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
The Journal of pathology 1997;181(1):14-24.
1996: De Gregorio L; Gallinari P; Gariboldi M; Manenti G; Pierotti M A; Jiricny J; Dragani T A
Genetic mapping of thymine DNA glycosylase (Tdg) gene and of one pseudogene in the mouse.
Mammalian genome : official journal of the International Mammalian Genome Society 1996;7(12):909-10.
1996: Greco A; Villa R; Pierotti M A
Genomic organization of the human NTRK1 gene.
Oncogene 1996;13(11):2463-6.
1996: Miozzo M; Perotti D; Minoletti F; Mondini P; Pilotti S; Luksch R; Fossati-Bellani F; Pierotti M A; Sozzi G; Radice P
Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors.
Genomics 1996;37(3):310-5.
1996: De Benedetti V M; Radice P; Mondini P; Spatti G; Conti A; Illeni M T; Caligo M A; Cipollini G; Bevilaqua G; Pilotti S; Pierotti M A
Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.
Oncogene 1996;13(6):1353-7.
1996: Fugazzola L; Pierotti M A; Vigano E; Pacini F; Vorontsova T V; Bongarzone I
Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
Oncogene 1996;13(5):1093-7.
1996: Dragani T A; Falvella F S; Manenti G; Pierotti M A; Gambetta R A
Downexpression of aldehyde dehydrogenase 1 in murine lung tumors.
Molecular carcinogenesis 1996;16(3):123-5.
1996: Dragani T A; Canzian F; Pierotti M A
A polygenic model of inherited predisposition to cancer.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(8):865-70.
1996: Sozzi G; Alder H; Tornielli S; Corletto V; Baffa R; Veronese M L; Negrini M; Pilotti S; Pierotti M A; Huebner K; Croce C M
Aberrant FHIT transcripts in Merkel cell carcinoma.
Cancer research 1996;56(11):2472-4.
1996: Borrello M G; Alberti L; Arighi E; Bongarzone I; Battistini C; Bardelli A; Pasini B; Piutti C; Rizzetti M G; Mondellini P; Radice M T; Pierotti M A
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.
Molecular and cellular biology 1996;16(5):2151-63.
1996: Bongarzone I; Fugazzola L; Vigneri P; Mariani L; Mondellini P; Pacini F; Basolo F; Pinchera A; Pilotti S; Pierotti M A
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1996;81(5):2006-9.
1996: Miozzo M; Sozzi G; Musso K; Pilotti S; Incarbone M; Pastorino U; Pierotti M A
Microsatellite alterations in bronchial and sputum specimens of lung cancer patients.
Cancer research 1996;56(10):2285-8.
1996: Minoletti F; Sozzi G; Calderone C; Di Palma S; Pilotti S; Azzarelli A; Pierotti M A
Variant translocation t(6;10)(p21;q22) in pulmonary chondroid hamartoma.
Genes, chromosomes & cancer 1996;15(4):246-8.
1996: Manenti G; Gariboldi M; Elango R; Fiorino A; De Gregorio L; Falvella F S; Hunter K; Housman D; Pierotti M A; Dragani T A
Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse.
Nature genetics 1996;12(4):455-7.
1996: Sozzi G; Veronese M L; Negrini M; Baffa R; Cotticelli M G; Inoue H; Tornielli S; Pilotti S; De Gregorio L; Pastorino U; Pierotti M A; Ohta M; Huebner K; Croce C M
The FHIT gene 3p14.2 is abnormal in lung cancer.
Cell 1996;85(1):17-26.
1996: DeGregorio L; Harshman K; Rosenthal J; Dragani T A; Pierotti M A
Genetic mapping of the Brca1 gene on mouse chromosome 11.
Mammalian genome : official journal of the International Mammalian Genome Society 1996;7(3):242.
1996: Righetti S C; Della Torre G; Pilotti S; Ménard S; Ottone F; Colnaghi M I; Pierotti M A; Lavarino C; Cornarotti M; Oriana S; Böhm S; Bresciani G L; Spatti G; Zunino F
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
Cancer research 1996;56(4):689-93.
1996: Perego P; Giarola M; Righetti S C; Supino R; Caserini C; Delia D; Pierotti M A; Miyashita T; Reed J C; Zunino F
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Cancer research 1996;56(3):556-62.
1996: Dragani T A; Canzian F; Manenti G; Pierotti M A
Hepatocarcinogenesis: a polygenic model of inherited predisposition to cancer.
Tumori 1996;82(1):1-5.
1995: Pilotti S; D'Amato L; Della Torre G; Donghi R; Longoni A; Giarola M; Sampietro G; De Palo G; Pierotti M A; Rilke F
Papillomavirus, p53 alteration, and primary carcinoma of the vulva.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1995;4(4):239-48.
1995: Dragani T A; Zeng Z B; Canzian F; Gariboldi M; Ghilarducci M T; Manenti G; Pierotti M A
Mapping of body weight loci on mouse chromosome X.
Mammalian genome : official journal of the International Mammalian Genome Society 1995;6(11):778-81.
1995: Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti M A
The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Molecular and cellular biology 1995;15(11):6118-27.
1995: Gariboldi M; Montecucco A; Columbano A; Ledda-Columbano G M; Savini E; Manenti G; Pierotti M A; Dragani T A
Genetic mapping and expression analysis of the murine DNA ligase I gene.
Molecular carcinogenesis 1995;14(2):71-4.
1995: Manenti G; Falvella F S; Gariboldi M; Dragani T A; Pierotti M A
Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2.
Genomics 1995;29(2):438-44.
1995: Gariboldi M; De Gregorio L; Ferrari S; Manenti G; Pierotti M A; Bianchi M E; Dragani T A
Mapping of the Hmg1 gene and of seven related sequences in the mouse.
Mammalian genome : official journal of the International Mammalian Genome Society 1995;6(9):581-5.
1995: Manenti G; De Gregorio L; Gariboldi M; Dragani T A; Pierotti M A
Analysis of loss of heterozygosity in murine hepatocellular tumors.
Molecular carcinogenesis 1995;13(3):191-200.
1995: Butti M G; Bongarzone I; Ferraresi G; Mondellini P; Borrello M G; Pierotti M A
A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Genomics 1995;28(1):15-24.
1995: Pedeutour F; Simon M P; Minoletti F; Sozzi G; Pierotti M A; Hecht F; Turc-Carel C
Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences.
Cancer research 1995;55(11):2400-3.
1995: Radice P; Perotti D; De Benedetti V; Mondini P; Radice M T; Pilotti S; Luksch R; Fossati Bellani F; Pierotti M A
Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
Genomics 1995;27(3):497-501.
1995: Minoletti F; Miozzo M; Pedeutour F; Sard L; Pilotti S; Azzarelli A; Turc-Carel C; Pierotti M A; Sozzi G
Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans.
Genes, chromosomes & cancer 1995;13(1):62-5.
1995: Gariboldi M; Manenti G; Dragani T A; Pierotti M A
Chromosome mapping of nine tropomyosin-related sequences in mice.
Mammalian genome : official journal of the International Mammalian Genome Society 1995;6(4):273-7.
1995: Bunone G; Borrello M G; Picetti R; Bongarzone I; Peverali F A; de Franciscis V; Della Valle G; Pierotti M A
Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis.
Experimental cell research 1995;217(1):92-9.
1995: Radice P; Pensotti V; Jones C; Perry H; Pierotti M A; Tunnacliffe A
The human archain gene, ARCN1, has highly conserved homologs in rice and Drosophila.
Genomics 1995;26(1):101-6.
1995: Pierotti M A; Bongarzone I; Borrello M G; Mariani C; Miranda C; Sozzi G; Greco A
Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.
Journal of endocrinological investigation 1995;18(2):130-3.
1995: Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed J C; Pierotti M A
Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
Blood 1995;85(2):359-67.
1994: Miranda C; Minoletti F; Greco A; Sozzi G; Pierotti M A
Refined localization of the human TPR gene to chromosome 1q25 by in situ hybridization.
Genomics 1994;23(3):714-5.
1994: Pilotti S; Collini P; Del Bo R; Cattoretti G; Pierotti M A; Rilke F
A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland.
The American journal of surgical pathology 1994;18(10):1054-64.
1994: Manenti G; Binelli G; Gariboldi M; Canzian F; De Gregorio L; Falvella F S; Dragani T A; Pierotti M A
Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice.
Genomics 1994;23(1):118-24.
1994: Minoletti F; Butti M G; Coronelli S; Miozzo M; Sozzi G; Pilotti S; Tunnacliffe A; Pierotti M A; Bongarzone I
The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2.
Genes, chromosomes & cancer 1994;11(1):51-7.
1994: Mariotti A; Marcora E; Bunone G; Costa A; Veronesi U; Pierotti M A; Della Valle G
N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells.
Journal of the National Cancer Institute 1994;86(16):1245-7.
1994: Dragani T A; Ribecco M; Manenti G; Pierotti M A; Testolin L; Guerriero C; Menapace L; Armato U
Morphology, growth, and gene expression in five newly isolated murine hepatocellular tumor cell lines.
Cancer letters 1994;83(1-2):269-76.
1994: Bongarzone I; Butti M G; Coronelli S; Borrello M G; Santoro M; Mondellini P; Pilotti S; Fusco A; Della Porta G; Pierotti M A
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
Cancer research 1994;54(11):2979-85.
1994: Borrello M G; Pelicci G; Arighi E; De Filippis L; Greco A; Bongarzone I; Rizzetti M; Pelicci P G; Pierotti M A
The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins.
Oncogene 1994;9(6):1661-8.
1994: Gariboldi M; Sturani E; Canzian F; De Gregorio L; Manenti G; Dragani T A; Pierotti M A
Genetic mapping of the mouse CDC25Mm gene, a ras-specific guanine nucleotide-releasing factor, to chromosome 9.
Genomics 1994;21(2):451-3.
1994: Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti M A
Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
The Journal of pathology 1994;172(4):337-42.
1994: Sozzi G; Bongarzone I; Miozzo M; Borrello M G; Blutti M G; Pilotti S; Della Porta G; Pierotti M A
A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.
Genes, chromosomes & cancer 1994;9(4):244-50.
1994: Della Torre G; Pilotti S; Donghi R; Pasquini G; Longoni A; Grandi C; Salvatori P; Pierotti M A; Rilke F
Epstein-Barr virus genomes in undifferentiated and squamous cell nasopharyngeal carcinomas in Italian patients.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1994;3(1):32-7.
1994: Canzian F; Gariboldi M; Manenti G; De Gregorio L; Osada S; Ohno S; Dragani T A; Pierotti M A
Expression in lung tumors and genetic mapping of the novel murine protein kinase C eta.
Molecular carcinogenesis 1994;9(3):111-3.
1994: Manenti G; Pilotti S; Re F C; Della Porta G; Pierotti M A
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):987-93.
1993: Pilotti S; Donghi R; D'Amato L; Giarola M; Longoni A; Della Torre G; De Palo G; Pierotti M A; Rilke F
HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1993;2(4):248-56.
1993: Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti M A
Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
Genomics 1993;18(2):397-400.
1993: Radice P; Pilotti S; De Benedetti V; Mondini P; Miozzo M; Luksch R; Fossati Bellani F; Della Porta G; Pierotti M A
Homozygous intragenic loss of the WT1 locus in a sporadic intralobar Wilms' tumor.
International journal of cancer. Journal international du cancer 1993;55(1):174-6.
1993: Greco A; Orlandi R; Mariani C; Miranda C; Borrello M G; Cattaneo A; Pagliardini S; Pierotti M A
Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(7):539-46.
1993: Borrello M G; Bongarzone I; Pierotti M A; Luksch R; Gasparini M; Collini P; Pilotti S; Rizzetti M G; Mondellini P; De Bernardi B
trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages.
International journal of cancer. Journal international du cancer 1993;54(4):540-5.
1993: Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti M A
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
The Journal of clinical investigation 1993;91(4):1753-60.
1993: Gariboldi M; Manenti G; Canzian F; Falvella F S; Radice M T; Pierotti M A; Della Porta G; Binelli G; Dragani T A
A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6.
Nature genetics 1993;3(2):132-6.
1993: Delia D; Lampugnani M G; Resnati M; Dejana E; Aiello A; Fontanella E; Soligo D; Pierotti M A; Greaves M F
CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro.
Blood 1993;81(4):1001-8.
1993: Gariboldi M; Manenti G; Canzian F; Falvella F S; Pierotti M A; Della Porta G; Binelli G; Dragani T A
Chromosome mapping of murine susceptibility loci to liver carcinogenesis.
Cancer research 1993;53(2):209-11.
1993: Bongarzone I; Monzini N; Borrello M G; Carcano C; Ferraresi G; Arighi E; Mondellini P; Della Porta G; Pierotti M A
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
Molecular and cellular biology 1993;13(1):358-66.
1993: Pilotti S; Donghi R; D'Amato L; Giarola M; Longoni A; Della Torre G; De Palo G; Pierotti M A; Rilke F
Papillomavirus, p53 alteration and primary carcinoma of the vulva.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):924-5.
1992: Sozzi G; Miozzo M; Cariani T C; Bongarzone I; Pilotti S; Pierotti M A; Della Porta G
A t(2;3)(q12-13;p24-25) in follicular thyroid adenomas.
Cancer genetics and cytogenetics 1992;64(1):38-41.
1992: Sozzi G; Miozzo M; Donghi R; Pilotti S; Cariani C T; Pastorino U; Della Porta G; Pierotti M A
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Cancer research 1992;52(21):6079-82.
1992: Della Torre G; Donghi R; de Campos Lima P O; Pasquini G; Pilotti S; Koronel R; Pierotti M A; De Palo G; Della Porta G; Rilke F
Human papillomavirus genomes in male urethral cells.
The American journal of pathology 1992;141(5):1181-6.
1992: Sozzi G; Bongarzone I; Miozzo M; Cariani C T; Mondellini P; Calderone C; Pilotti S; Pierotti M A; Della Porta G
Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas.
Genes, chromosomes & cancer 1992;5(3):212-8.
1992: Martinotti A; Cariani C T; Melani C; Sozzi G; Spurr N K; Pierotti M A; Colombo M P
Isolation and mapping to 17p12-13 of the human homologous of the murine growth arrest specific Gas-3 gene.
Human molecular genetics 1992;1(5):331-4.
1992: Santoro M; Carlomagno F; Hay I D; Herrmann M A; Grieco M; Melillo R; Pierotti M A; Bongarzone I; Della Porta G; Berger N
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
The Journal of clinical investigation 1992;89(5):1517-22.
1992: Pierotti M A; Santoro M; Jenkins R B; Sozzi G; Bongarzone I; Grieco M; Monzini N; Miozzo M; Herrmann M A; Fusco A
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1616-20.
1992: Delia D; Aiello A; Soligo D; Fontanella E; Melani C; Pezzella F; Pierotti M A; Della Porta G
bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.
Blood 1992;79(5):1291-8.
1992: Miozzo M; Sozzi G; Cariani C T; Di Palma S; Luksch R; Azzarelli A; Pierotti M A; Della Porta G
A synovial sarcoma with t(X;18)(p11;q11) in a patient with Turner's syndrome.
Genes, chromosomes & cancer 1992;4(2):192-3.
1992: Della Torre G; Donghi R; Longoni A; Pilotti S; Pasquini G; De Palo G; Pierotti M A; Rilke F; Della Porta G
HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1992;1(1):25-30.
1992: Pierotti M A; Dragani T A
Genetics and cancer.
Current opinion in oncology 1992;4(1):127-33.
1992: Borrello M G; Pierotti M A; Tamborini E; Biassoni D; Rizzetti M G; Pilotti S; Della Porta G
DNA methylation of coding and non-coding regions of the human H-RAS gene in normal and tumor tissues.
Oncogene 1992;7(2):269-75.
1992: Greco A; Pierotti M A; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Oncogene 1992;7(2):237-42.
1992: Aiello A; Delia D; Borrello M G; Biassoni D; Giardini R; Fontanella E; Pezzella F; Pulford K; Pierotti M; Della Porta G
Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.
Cytometry 1992;13(5):502-9.
1992: Re F C; Manenti G; Borrello M G; Colombo M P; Fisher J H; Pierotti M A; Della Porta G; Dragani T A
Multiple molecular alterations in mouse lung tumors.
Molecular carcinogenesis 1992;5(2):155-60.
1991: Radice P; Sozzi G; Miozzo M; De Benedetti V; Cariani T; Bongarzone I; Spurr N K; Pierotti M A; Della Porta G
The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31.
Oncogene 1991;6(11):2145-8.
1991: Michieli P; Pierotti M A; De Benedetti V; Donghi R; Mondini P; Radice P; Della Porta G
TaqI RFLP of the human tropomyosin gene (TPM3) involved in the generation of the TRK oncogene.
Nucleic acids research 1991;19(17):4796.
1991: Radice P; Borrello M G; De Benedetti V; Mondini P; Pierotti M A; Della Porta G
SacI identifies an additional RFLP at the D11S12 locus.
Nucleic acids research 1991;19(7):1717.
1991: Sozzi G; Pierotti M A; Miozzo M; Donghi R; Radice P; De Benedetti V; Grieco M; Santoro M; Fusco A; Vecchio G
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.
Oncogene 1991;6(2):339-42.
1991: Dragani T A; Manenti G; Colombo B M; Falvella F S; Gariboldi M; Pierotti M A; Della Porta G
Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
Oncogene 1991;6(2):333-8.
1991: Carbone G; Borrello M G; Molla A; Rizzetti M G; Pierotti M A; Della Porta G; Parmiani G
Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas.
International journal of cancer. Journal international du cancer 1991;47(4):619-25.
1991: Sozzi G; Miozzo M; Tagliabue E; Calderone C; Lombardi L; Pilotti S; Pastorino U; Pierotti M A; Della Porta G
Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients.
Cancer research 1991;51(1):400-4.
1990: Sozzi G; Miozzo M; Di Palma S; Minelli A; Calderone C; Danesino C; Pastorino U; Pierotti M A; Della Porta G
Involvement of the region 13q14 in a patient with adamantinoma of the long bones.
Human genetics 1990;85(5):513-5.
1990: Miozzo M; Pierotti M A; Sozzi G; Radice P; Bongarzone I; Spurr N K; Della Porta G
Human TRK proto-oncogene maps to chromosome 1q32-q41.
Oncogene 1990;5(9):1411-4.
1990: Miozzo M; Sozzi G; Calderone C; Pilotti S; Lombardi L; Pierotti M A; Della Porta G
t(11;22) in three cases of peripheral neuroepithelioma.
Genes, chromosomes & cancer 1990;2(2):163-5.
1990: Sozzi G; Miozzo M; Orazi A; Calderone C; Castellano M; Viviani S; Santoro A; Pierotti M A; Della Porta G
Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
British journal of cancer 1990;61(3):425-8.
1990: Grieco M; Santoro M; Berlingieri M T; Melillo R M; Donghi R; Bongarzone I; Pierotti M A; Della Porta G; Fusco A; Vecchio G
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Cell 1990;60(4):557-63.
1990: Sozzi G; Miozzo M; Calderone C; Fossati G; Pierotti M A; Cascinelli N; Della Porta G
Chromosome abnormalities and fragile sites in human melanoma.
Cancer genetics and cytogenetics 1990;44(1):61-7.
1989: Bongarzone I; Pierotti M A; Monzini N; Mondellini P; Manenti G; Donghi R; Pilotti S; Grieco M; Santoro M; Fusco A
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.
Oncogene 1989;4(12):1457-62.
1989: Delia D; Borrello M G; Berti E; Pierotti M A; Biassoni D; Gianotti R; Alessi E; Rizzetti M G; Caputo R; Della Porta G
Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.
Cancer research 1989;49(17):4901-5.
1989: Della Porta G; Radice P; Pierotti M A
Onco-suppressor genes in human cancer.
Tumori 1989;75(4):329-36.
1989: Donghi R; Sozzi G; Pierotti M A; Biunno I; Miozzo M; Fusco A; Grieco M; Santoro M; Vecchio G; Spurr N K
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A).
Oncogene 1989;4(4):521-3.
1989: Radice P; Pierotti M A; Lacerenza S; Mondini P; Radice M T; Pilotti S; Della Porta G
Loss of heterozygosity in human germinal tumors.
Cytogenetics and cell genetics 1989;52(1-2):72-6.
1988: Della Torre G; Muttini M; Ballinari D; Ferrari G; Pierotti M A; Della Porta G
Characterization of papillomavirus polypeptides from bovine cutaneous fibropapillomas.
The Journal of general virology 1988;69 ( Pt 11)():2919-24.
1988: Radice P; Donghi R; Pierotti M A; Longoni A; Fusco A; Grieco M; Santoro M; Vecchio G; Della Porta G
RFLP for TaqI of the human thyroid papillary carcinoma (PTC) oncogene.
Nucleic acids research 1988;16(18):9062.
1988: Borrello M G; Carbone G; Pierotti M A; Molla A; Della Porta G
Activated c-K-ras and c-N-ras oncogenes in 3-methylcholanthrene-induced BALB/c fibrosarcomas.
Carcinogenesis 1988;9(8):1517-9.
1988: Biunno I; Pozzi M R; Radice P; Mondini P; Pierotti M A; Haley J; Waterfield M D; Della Porta G
BglII polymorphism of the epidermal growth factor receptor (EGF-R) gene.
Nucleic acids research 1988;16(15):7753.
1988: Biunno I; Pozzi M R; Pierotti M A; Pilotti S; Cattoretti G; Della Porta G
Structure and expression of oncogenes in surgical specimens of human breast carcinomas.
British journal of cancer 1988;57(5):464-8.
1988: Alzani R; Pierotti M A; Ménard S; Canevari S; Fertonani M L; Ballinari D; Traversari C; Della Torre G; Radice P; Pilotti S
Monoclonal antibodies against NIH 3T3 cells transformed by human thyroid carcinoma DNA.
Hybridoma 1988;7(1):7-18.
1988: Sozzi G; Bertoglio M G; Pilotti S; Rilke F; Pierotti M A; Della Porta G
Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma.
Cancer genetics and cytogenetics 1988;30(1):151-8.
1988: Grieco M; Santoro M; Berlingieri M T; Donghi R; Pierotti M A; Della Porta G; Fusco A; Vecchio G
Molecular cloning of PTC, a new oncogene found activated in human thyroid papillary carcinomas and their lymph node metastases.
Annals of the New York Academy of Sciences 1988;551():380-1.
1988: Borrello M G; Pierotti M A; Donghi R; Bongarzone I; Cattadori M R; Traversari C; Mondellini P; Della Porta G
Modulation of the human Harvey-ras oncogene expression by DNA methylation.
Oncogene research 1988;2(2):197-203.
1987: Sozzi G; Bertoglio M G; Borrello M G; Gianì S; Pilotti S; Pierotti M; Della Porta G
Chromosomal abnormalities in a primary small cell lung cancer.
Cancer genetics and cytogenetics 1987;27(1):45-50.
1987: Borrello M G; Pierotti M A; Bongarzone I; Donghi R; Mondellini P; Della Porta G
DNA methylation affecting the transforming activity of the human Ha-ras oncogene.
Cancer research 1987;47(1):75-9.
1987: Sozzi G; Agresti A; Bertoglio M G; Borrello M G; Delia D; Giardini R; Pierotti M A; Rilke F; Della Porta G
A cytogenetic, phenotypic, and molecular study of an immunoblastic lymphoma with a 14q + translocation.
Cytogenetics and cell genetics 1987;45(3-4):213-7.
1987: Traversari C; Ferrari G; Grazioli L; Ballinari D; Colombo M P; Castelli C; Pierotti M A; Parmiani G
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity.
Experimental and clinical immunogenetics 1987;4(2):106-14.
1987: Radice P; Pierotti M A; Borrello M G; Illeni M T; Rovini D; Della Porta G
HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
Oncogene 1987;2(1):91-5.
1986: Pierotti M A; Radice P; Biunno I; Borrello M G; Cattadori M R; Della Porta G
Two RFLPs generated by Taq I at the human HRAS1 locus.
Nucleic acids research 1986;14(10):4379.
1986: Pierotti M A; Radice P; Biunno I; Borrello M G; Cattadori M R; Della Porta G
Detection of two TaqI polymorphisms in the VTR region of the human HRAS1 oncogene.
Cytogenetics and cell genetics 1986;43(3-4):174-80.
1985: Carbone G; Pierotti M A; Boiocchi M; De Leo A B; Ballinari D; Radice P; Borrello M G; Meseguer A; Cernuschi A; Parmiani G
Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
Cancer research 1985;45(10):4980-5.
1984: Pierotti M A; Traversari C; Ballinari D; Borrello M G; Parmiani G
Ly-5 molecular forms in congenitally immunodeficient mice.
Experimental and clinical immunogenetics 1984;1(2):75-82.
1983: Pierotti M A; Ballinari D; Colombo M P; Grazioli L; Parmiani G
Role of the carbohydrate prosthetic groups in the biosynthesis of membrane antigens and in the H-2-restricted lysis of MBL-2 lymphoma cells.
Transplantation proceedings 1983;15(4):2068-73.
1983: Ballinari D; Pierotti M A; Sensi M L; Parmiani G
Lack of H-2Ld locus products on a BALB/c fibrosarcoma expressing H-2k-like alien antigens.
Journal of immunogenetics 1983;10(2):115-25.
1982: Ballinari D; Pierotti M A; Grazioli L; Cattaneo M; Rogers M J; Parmiani G
Biochemical analysis of a public H-2 specificity revealed by an anomalous reaction of an alloantiserum with a chemically induced C57BL/10 fibrosarcoma.
Journal of immunogenetics 1982;9(4):267-75.
1982: Parmiani G; Sensi M L; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
International journal of cancer. Journal international du cancer 1982;29(3):323-32.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Marco Pierotti

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Physiology

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Marco Pierotti (preview)

All Publications